Ranjan Chakrabarti

Over the past two decades, India’s pharmaceutical industry has evolved from a largely generic-focused manufacturing sector into a far more complex ecosystem that now includes biologics, vaccines, biosimilars, complex APIs, contract research and manufacturing (CRAMS), and an emerging medtech and digital health scene.

Cell & Gene Therapy Insights 2023; 9(2), 195–201 DOI: 10.18609/cgti.2023.029 Chimeric antigen receptor (CAR)-T cell therapies are promising treatments for previously untreatable cancers. However, many hurdles still need to be cleared before these products become widely accessible, especially to patients in low- and middle-income countries.

Our weekly roundup of books that should be on your radar. We love stories, and even in the age of Netflix-and-chill, there's nothing like a good book that promises a couple of hours of absorption — whether curled up in bed, in your favourite coffeehouse, or that long (and tiresome) commute to work. Every Sunday, we'll have a succinct pick of books, across diverse genres, that have been newly made available for your reading pleasure.